Hearing News Watch

Featured image for “Eli Lilly Partners with Rznomics in $1.3B Deal to Develop RNA Hearing Therapies”
May. 16, 2025

Eli Lilly Partners with Rznomics in $1.3B Deal to Develop RNA Hearing Therapies

HHTM
SEONGNAM, SOUTH KOREA — Rznomics Inc., a South Korea-based clinical-stage biopharmaceutical company, has entered a strategic global research and licensing agreement with Eli Lilly and Company to co-develop RNA-editing therapies for sensorineural hearing loss. The collaboration marks another major step in Lilly’s expanding footprint in the field of genetic hearing restoration. Under the agreement, Rznomics will lead early-stage discovery using
Featured image for “Secondary Analysis of ACHIEVE Trial Finds Hearing Intervention Cuts Cognitive Decline by 62% in At-Risk Group”
May. 16, 2025

Secondary Analysis of ACHIEVE Trial Finds Hearing Intervention Cuts Cognitive Decline by 62% in At-Risk Group

HHTM
A secondary analysis of the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) trial suggests that hearing intervention may significantly slow cognitive decline in older adults—particularly those at greatest risk. The findings, published May 14, 2025, in Alzheimer’s & Dementia, show a 62% reduction in the rate of cognitive decline over three years among individuals with the highest predicted risk,
Featured image for “ReSound’s “Gift of Hearing” Campaign Provides Free Hearing Aids to 390 People”
May. 13, 2025

ReSound’s “Gift of Hearing” Campaign Provides Free Hearing Aids to 390 People

HHTM
BLOOMINGTON, MINNESOTA – ReSound has announced the results of its annual Gift of Hearing campaign, during which 293 hearing care practices across the United States and Canada donated a total of 780 hearing aids to 390 people. Running from December 2024 through April 2025, this year’s initiative marked the campaign’s highest participation and impact since its launch in 2020. Since
Featured image for “Starkey’s Brandon Sawalich Named Best MedTech Company CEO in 2025 MedTech Breakthrough Awards”
May. 12, 2025

Starkey’s Brandon Sawalich Named Best MedTech Company CEO in 2025 MedTech Breakthrough Awards

HHTM
EDEN PRAIRIE, MINNESOTA – Brandon Sawalich, President and CEO of Starkey, has been named Best MedTech Company CEO by the 2025 MedTech Breakthrough Awards. The annual awards program recognizes excellence and innovation across the global health and medical technology industry. Sawalich has served as Starkey’s President and CEO since 2017, leading the company through a period of strategic expansion and
Featured image for “Sonova Reports Full-Year Growth and Names Eric Bernard as Next CEO”
May. 09, 2025

Sonova Reports Full-Year Growth and Names Eric Bernard as Next CEO

HHTM
STAEFA, SWITZERLAND – Sonova Holding AG announced its financial results for the fiscal year 2024/25, reporting growth across all four business segments and confirming a planned CEO transition. The company saw full-year sales of CHF 3.87 billion (~$4.26 billion USD), marking a 7.6% increase in local currencies and a 6.6% rise in Swiss francs. Adjusted EBITA grew 7.4% in local
Featured image for “Management of the Tinnitus and Hyperacusis Patient – 32nd Annual International Conference”
May. 09, 2025

Management of the Tinnitus and Hyperacusis Patient – 32nd Annual International Conference

HHTM
IOWA CITY, IA — The University of Iowa has announced the upcoming 32nd annual Management of the Tinnitus & Hyperacusis Patient international conference, which is set to take place from August 14-15, both in-person and remotely. In-Person venue will be held at Wendell Johnson Speech & Hearing Center. The popular conference is intended for otologists, audiologists, psychologists, hearing aid specialists
Featured image for “WSA Reports 1% Organic Revenue Growth and 22% EBITDA Increase in Q2 FY 2024/25”
May. 08, 2025

WSA Reports 1% Organic Revenue Growth and 22% EBITDA Increase in Q2 FY 2024/25

HHTM
LYNGE, DENMARK – WSA, a global hearing healthcare group, reported financial results for the second quarter of fiscal year 2024/25 (January 1–March 31, 2025), with organic revenue growth of 1% and a 22% increase in EBITDA. This reflects an improvement of 2.8 percentage points in the company’s EBITDA margin. “With an organic revenue growth of 1% in a volatile macro environment
Featured image for “Children’s Hospital Los Angeles Develops First Machine Learning Tool to Predict Risk of Cisplatin-Induced Hearing Loss”
May. 07, 2025

Children’s Hospital Los Angeles Develops First Machine Learning Tool to Predict Risk of Cisplatin-Induced Hearing Loss

HHTM
LOS ANGELES, CALIFORNIA – An international research team led by Dr. Etan Orgel at Children’s Hospital Los Angeles (CHLA) has developed a machine learning model designed to estimate a child’s risk of developing hearing loss after receiving the chemotherapy drug cisplatin. The tool, known as PedsHEAR, was built using routinely available clinical information and has demonstrated 95% predictive accuracy. Results
Featured image for “Study Identifies Facial and Eye Biomarkers That Reflect Tinnitus Distress”
May. 04, 2025

Study Identifies Facial and Eye Biomarkers That Reflect Tinnitus Distress

HHTM
A new study published in Science Translational Medicine has identified involuntary facial and eye responses that may serve as objective biomarkers of tinnitus-related distress. The findings, from researchers at Mass General Brigham, mark a potential breakthrough for advancing diagnostics and evaluating treatments for tinnitus, a condition that affects millions of people worldwide. The team, led by Dr. Daniel Polley of
Featured image for “Colorado Audiology Symposium to Explore Clinically Meaningful Change in Hearing and Balance”
May. 03, 2025

Colorado Audiology Symposium to Explore Clinically Meaningful Change in Hearing and Balance

HHTM
AURORA, COLORADO – On Friday, June 28, the Department of Otolaryngology – Head and Neck Surgery at the University of Colorado Anschutz Medical Campus will host the Colorado Audiology Symposium at the Donald E. Elliman Conference Center, with hybrid attendance options available both in-person and virtually. The event will run from 8:00 a.m. to 3:00 p.m. and includes breakfast and